Skeletal Muscle Loss and Octogenarian Status Are Associated with S-1 Adjuvant Therapy Discontinuation and Poor Prognosis after Pancreatectomy
The efficacy and prognosis of adjuvant chemotherapy for resected pancreatic cancer remain unclear. We investigated the utility and risk factors of S-1 adjuvant chemotherapy in patients with pancreatic cancer undergoing pancreatectomy. This study comprised 80 patients, including 58 patients who recei...
Main Authors: | Mariko Tsukagoshi, Norifumi Harimoto, Kenichiro Araki, Norio Kubo, Akira Watanabe, Takamichi Igarashi, Norihiro Ishii, Takahiro Yamanaka, Kei Hagiwara, Kouki Hoshino, Ryo Muranushi, Toshiki Yajima, Ken Shirabe |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/16/4105 |
Similar Items
-
Usefulness of serum creatinine and cystatin C ratio as a screening tool for predicting prognosis in patients with pancreatic cancer
by: Mariko Tsukagoshi, et al.
Published: (2023-09-01) -
RNF31 promotes proliferation and invasion of hepatocellular carcinoma via nuclear factor kappaB activation
by: Kouki Hoshino, et al.
Published: (2024-01-01) -
Lower Geriatric Nutritional Risk Index and Prognostic Nutritional Index Predict Postoperative Prognosis in Patients with Hepatocellular Carcinoma
by: Mariko Tsukagoshi, et al.
Published: (2024-03-01) -
Laparoscopic hepatectomy for hepatocellular carcinoma in a patient with congenital factor V deficiency: a case report
by: Takaomi Seki, et al.
Published: (2022-10-01) -
Fibrolamellar hepatocellular carcinoma: a case report and gene analysis
by: Akira Watanabe, et al.
Published: (2023-09-01)